-
Innovation Ranking
Innovation Ranking – Neste Corp
Neste Corp (Neste) is an oil refining and marketing company provider of renewable traffic fuels. It produces and sells gasoline; diesel fuel; aviation fuel; heating oil; light and heavy fuel oil; base oils; gasoline components; specialty fuels; solvents; liquid petroleum gas (LPG), bitumen, renewable diesel, and renewable aviation fuel. The company undertakes direct sales and marketing of petroleum products around the Baltic region. It has operations in Finland, Singapore Northwest Russia, Estonia, Latvia, and Lithuania. It also exports oil and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nest-1 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nest-1 in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nest-1 in Melanoma Drug Details: NST-628 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nest-1 in Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nest-1 in Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nest-1 in Glioma Drug Details: NST-628 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nest-1 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nest-1 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nest-1 in Non-Small Cell Lung Cancer Drug Details: NST-628...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-101 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-101 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-101 in Mantle Cell Lymphoma Drug Details: AT-101 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-101 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-101 in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-101 in Follicular Lymphoma Drug Details: AT-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-101 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-101 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-101 in Diffuse Large B-Cell Lymphoma Drug Details: AT-101...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-101 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-101 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-101 in Marginal Zone B-cell Lymphoma Drug Details: AT-101...
-
Product Insights
NewQuarterly Sparkling Wine pricing trends in South Africa
Empower your strategies with our Quarterly Sparkling Wine pricing trends in South Africa report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important...
-
Product Insights
Hawks Nest
Hawks Nest is a Hydro project located in West Virginia, United States. The project is owned by Brookfield Renewable Partners LP. The project came online in 1936. Empower your strategies with our Hawks Nest report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...